News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
15,333 Results
Type
Article (372)
Press Release (14954)
Section
Business (8498)
Career Advice (13)
Deals (1028)
Drug Delivery (1)
Drug Development (1318)
FDA (223)
Job Trends (370)
News (10009)
Policy (338)
Tag
Academia (19)
Accelerated approval (1)
ADA (4)
Allergies (1)
Alliances (289)
ALS (1)
Alzheimer's disease (24)
Antibody-drug conjugate (ADC) (28)
Approvals (254)
Artificial intelligence (6)
ASCO (7)
Autoimmune disease (21)
Bankruptcy (2)
Best Places to Work (335)
Biosimilars (2)
Biotechnology (1)
Bladder cancer (7)
Brain cancer (1)
Breast cancer (30)
Cancer (231)
Cardiovascular disease (19)
Career advice (12)
Career pathing (1)
CAR-T (11)
Cell therapy (15)
Cervical cancer (2)
Clinical research (1400)
Collaboration (22)
Company closure (1)
Compensation (13)
Complete response letters (1)
COVID-19 (28)
CRISPR (8)
C-suite (5)
Cystic fibrosis (5)
Data (316)
Depression (3)
Dermatology (5)
Diabetes (28)
Diagnostics (218)
Digital health (3)
Drug discovery (2)
Drug pricing (3)
Duchenne muscular dystrophy (3)
Earnings (9095)
Editorial (2)
Events (1129)
Executive appointments (5)
FDA (406)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Funding (21)
Gene editing (12)
Gene therapy (9)
GLP-1 (29)
Government (40)
Guidances (106)
Healthcare (520)
Hematology (5)
IgA nephropathy (5)
Immunology and inflammation (8)
Immuno-oncology (7)
Indications (11)
Infectious disease (29)
Inflammatory bowel disease (3)
Influenza (1)
Intellectual property (2)
Interviews (1)
IPO (877)
Job creations (43)
Job search strategy (11)
Kidney cancer (1)
Kidney disease (3)
Labor market (4)
Layoffs (9)
Legal (42)
Liver cancer (4)
Lung cancer (49)
Lymphoma (18)
Manufacturing (11)
MASH (5)
Medical device (438)
Medtech (451)
Mergers & acquisitions (172)
Metabolic disorders (53)
mRNA (4)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (8)
Neuropsychiatric disorders (5)
Neuroscience (57)
NextGen: Class of 2026 (101)
Non-profit (37)
Obesity (16)
Opinion (1)
Ovarian cancer (30)
Pain (5)
Pancreatic cancer (9)
Parkinson's disease (4)
Patents (7)
Patient recruitment (11)
Patient selection (1)
Peanut (1)
People (207)
Peptides (2)
Phase 1 (246)
Phase 2 (553)
Phase 3 (687)
Pipeline (856)
Policy (1)
Postmarket research (60)
Preclinical (76)
Prostate cancer (6)
Radiopharmaceuticals (8)
Rare diseases (30)
Real estate (42)
Regulatory (354)
Reports (4)
Research institute (26)
Schizophrenia (5)
Series A (2)
Series B (2)
Sickle cell disease (4)
Special edition (6)
Spinal muscular atrophy (1)
Startups (23)
Tariffs (2)
The Weekly (1)
Vaccines (10)
Venture capital (2)
Weight loss (18)
Women's health (3)
Date
Today (2)
Last 7 days (12)
Last 30 days (50)
Last 365 days (1159)
2026 (851)
2025 (1086)
2024 (1156)
2023 (1444)
2022 (1522)
2021 (1539)
2020 (1360)
2019 (881)
2018 (743)
2017 (564)
2016 (342)
2015 (542)
2014 (414)
2013 (232)
2012 (301)
2011 (319)
2010 (290)
Location
Africa (8)
Alabama (5)
Alaska (1)
Arizona (6)
Asia (1214)
Australia (58)
California (553)
Canada (134)
China (76)
Colorado (32)
Connecticut (24)
Delaware (18)
Europe (1962)
Florida (132)
Georgia (22)
Idaho (2)
Illinois (54)
India (1)
Indiana (25)
Japan (21)
Kansas (2)
Kentucky (1)
Louisiana (3)
Maine (4)
Maryland (53)
Massachusetts (339)
Michigan (17)
Minnesota (27)
Missouri (4)
Montana (1)
Nevada (7)
New Hampshire (6)
New Jersey (194)
New York (125)
North Carolina (85)
Northern California (303)
Ohio (17)
Oregon (1)
Pennsylvania (127)
South America (18)
Southern California (218)
Tennessee (4)
Texas (63)
United States (1987)
Utah (24)
Virginia (5)
Washington State (36)
Wisconsin (2)
15,333 Results for "112".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gynecology Drugs Market Size to Reach USD 112.6 Billion by 2034 Rising Gynecological Disorders and Health Awareness Drive Market Growth
The global gynecology drugs market size is forecasted to reach around USD 112.6 billion by 2034, increasing from USD 69.79 billion in 2024 and representing a remarkable CAGR of 4.9% from 2025 to 2034.
October 16, 2025
·
1 min read
Press Releases
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
July 7, 2026
·
7 min read
Press Releases
Factor Bioscience to Showcase Engineered iMacrophages (FACT-112) Targeting Ovarian Cancer In Vivo at ISCT 2026
April 30, 2026
·
2 min read
Gene editing
Lilly Leans Into Hearing Loss in $1.12B+ Gene Editing Pact With Seamless
The deal will help bolster Eli Lilly’s growing hearing loss portfolio, which is anchored by the gene therapy AK-OTOF.
January 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment
April 28, 2026
·
11 min read
Press Releases
Caldera Therapeutics Launches with $112.5 Million and Announces First Subjects Dosed in Phase 1 Trial of First-In-Class Bispecific Antibody CLD-423 for Inflammatory Bowel Disease
January 15, 2026
·
2 min read
Press Releases
Promontory Therapeutics Announces Interim Efficacy Requirement Reached on Phase 2 Study of PT-112 Monotherapy in Patients with Recurrent Thymoma
December 23, 2025
·
4 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
Downstream Processing Market Size to Surge USD 112.86 Billion by 2034
February 26, 2025
·
1 min read
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Zura Bio Limited today announced that it has entered into subscription agreements for a private placement that is expected to result in gross proceeds of approximately $112.5 million, before deducting placement agent fees and offering expenses (the “Private Placement”).
April 18, 2024
·
7 min read
1 of 1,534
Next
